These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 20619105)
1. [Effect of RNAi silencing of theWT1 gene on the apoptosis of human hepatocellular carcinoma cell hepG2]. Huang XQ Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Aug; 26(8):771-3. PubMed ID: 20619105 [TBL] [Abstract][Full Text] [Related]
2. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2]. Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068 [TBL] [Abstract][Full Text] [Related]
3. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy. Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340 [TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2]. Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759 [TBL] [Abstract][Full Text] [Related]
5. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells. Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401 [TBL] [Abstract][Full Text] [Related]
6. [Suppression of c-myc expression by interference RNA in HepG2 hepatocellular carcinoma cells]. Xu Y; Wang YH; Gao JD; Ye J; Zhu HX; Xu NZ; Wang XY; Sun ZT Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):458-60. PubMed ID: 15555332 [TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of RNAi targeting human telomerase reverse transcriptase against human hepatocellular carcinoma cells]. Li H; Wang XL; Yang Y; Zhang J; Wang GS; Jiang N; Chen GH Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1323-6. PubMed ID: 18753050 [TBL] [Abstract][Full Text] [Related]
8. [The inhibition effect and its molecular mechanism of human cervical cancer oncogene siRNA on hepatocarcinoma cells]. Yang Y; Zhou XF; Liu AD Zhonghua Gan Zang Bing Za Zhi; 2008 Aug; 16(8):612-5. PubMed ID: 18752750 [TBL] [Abstract][Full Text] [Related]
9. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro]. Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of fractalkine inhibits the in vitro and in vivo angiogenesis of the hepatocellular carcinoma HepG2 cells. Li F; Wang Z; Liu Y; Li J Oncol Rep; 2010 Sep; 24(3):669-75. PubMed ID: 20664972 [TBL] [Abstract][Full Text] [Related]
11. [Inhibition of HSP70-2 expression by RNA interference induces apoptosis of human hepatocellular carcinoma cells]. Xia LM; Tian DA; Zhang Q; Yan W; Wang B; Liu M; Li PY; Chen B Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):678-82. PubMed ID: 18822209 [TBL] [Abstract][Full Text] [Related]
12. Leucine-rich protein 130 contributes to apoptosis resistance of human hepatocarcinoma cells. Michaud M; Barakat S; Magnard S; Rigal D; Baggetto LG Int J Oncol; 2011 Jan; 38(1):169-78. PubMed ID: 21109938 [TBL] [Abstract][Full Text] [Related]
13. RNA interference-mediated silencing of Stat5 induces apoptosis and growth suppression of hepatocellular carcinoma cells. Zhang L; Zhao Z; Feng Z; Yin N; Lu G; Shan B Neoplasma; 2012; 59(3):302-9. PubMed ID: 22296499 [TBL] [Abstract][Full Text] [Related]
14. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference]. Xu JY; Chen LB; Xu JY; Yang Z; Xu RH; Wei HY Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):481-4. PubMed ID: 16772086 [TBL] [Abstract][Full Text] [Related]
15. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference]. Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658 [TBL] [Abstract][Full Text] [Related]
16. Deleted in liver cancer 2 suppresses cell growth via the regulation of the Raf-1-ERK1/2-p70S6K signalling pathway. Leung TH; Yam JW; Chan LK; Ching YP; Ng IO Liver Int; 2010 Oct; 30(9):1315-23. PubMed ID: 20629949 [TBL] [Abstract][Full Text] [Related]
17. [The relationship between microRNA-18 and BTG2 in the carcinogenesis of hepatocellular carcinoma]. Li Q; Wang G; Zhang ZM Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):42-5. PubMed ID: 19203451 [TBL] [Abstract][Full Text] [Related]
18. Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA. Shi Y; Wang SY; Yao M; Sai WL; Wu W; Yang JL; Cai Y; Zheng WJ; Yao DF World J Gastroenterol; 2015 Dec; 21(45):12814-21. PubMed ID: 26668505 [TBL] [Abstract][Full Text] [Related]
19. KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis. Sirach E; Bureau C; Péron JM; Pradayrol L; Vinel JP; Buscail L; Cordelier P Cell Death Differ; 2007 Jun; 14(6):1202-10. PubMed ID: 17347668 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines. Di Fazio P; Montalbano R; Neureiter D; Alinger B; Schmidt A; Merkel AL; Quint K; Ocker M Exp Cell Res; 2012 Sep; 318(15):1832-43. PubMed ID: 22683924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]